The present and future of nanotechnology in human health care.

Nanotechnology is a multidisciplinary field that covers a vast and diverse array of devices derived from engineering, physics, chemistry, and biology. The burgeoning new field of nanotechnology, opened up by rapid advances in science and technology, creates myriad new opportunities for advancing medical science and disease treatment in human health care. Applications of nanotechnology to medicine and physiology imply materials and devices designed to interact with the body at subcellular (i.e., molecular) scales with a high degree of specificity. This can be potentially translated into targeted cellular and tissue-specific clinical applications designed to achieve maximal therapeutic efficacy with minimal side effects. In this review the chief scientific and technical aspects of nanotechnology are introduced, and some of its potential clinical applications are discussed.

[1]  P. Hoet,et al.  Nanoparticles – known and unknown health risks , 2004, Journal of nanobiotechnology.

[2]  M Addy,et al.  Dentine hypersensitivity. A study of the patency of dentinal tubules in sensitive and non-sensitive cervical dentine. , 1987, Journal of clinical periodontology.

[3]  P. Couvreur,et al.  A relevant in vitro rat model for the evaluation of blood-brain barrier translocation of nanoparticles , 2005, Cellular and Molecular Life Sciences.

[4]  T. Webster,et al.  Enhanced functions of osteoblasts on nanophase ceramics. , 2000, Biomaterials.

[5]  V. Labhasetwar,et al.  Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. , 2002, International journal of pharmaceutics.

[6]  M. Bednarski,et al.  Molecular Imaging Applications in Nanomedicine , 2004, Biomedical microdevices.

[7]  Robert A Freitas,et al.  What is nanomedicine? , 2005, Disease-a-month : DM.

[8]  J. Popma,et al.  Clinical trials in interventional cardiology. , 1999, Current opinion in cardiology.

[9]  Jian Yi Li,et al.  Organ-specific gene expression in the rhesus monkey eye following intravenous non-viral gene transfer. , 2003, Molecular vision.

[10]  Thomas J. Webster,et al.  Helical rosette nanotubes: a more effective orthopaedic implant material , 2004 .

[11]  M. Leon,et al.  Vascular Complications After Balloon and New Device Angioplasty , 1993, Circulation.

[12]  J. Hamman,et al.  Oral delivery of peptide drugs: barriers and developments. , 2005, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.

[13]  Antony D'Emanuele,et al.  Dendrimer-drug interactions. , 2005, Advanced drug delivery reviews.

[14]  S. Sahoo,et al.  Nanotech approaches to drug delivery and imaging. , 2003, Drug discovery today.

[15]  G. Hunt,et al.  Nanotechnology and public health. , 2005, [Nihon koshu eisei zasshi] Japanese journal of public health.

[16]  Alexander T Florence,et al.  Supramolecular structures from dendrons and dendrimers. , 2005, Advanced drug delivery reviews.

[17]  Liandong Hu,et al.  Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs , 2004, The Journal of pharmacy and pharmacology.

[18]  Dwaine F Emerich,et al.  Nanomedicine – prospective therapeutic and diagnostic applications , 2005, Expert opinion on biological therapy.

[19]  A. Schätzlein,et al.  Dendrimers in gene delivery. , 2005, Advanced drug delivery reviews.

[20]  M. Alonso,et al.  Chitosan-PEG nanocapsules as new carriers for oral peptide delivery. Effect of chitosan pegylation degree. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[21]  D. A. Kharkevich,et al.  Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study. , 1998, Journal of microencapsulation.

[22]  John Samuel,et al.  Analysis of Poly(D,L-Lactic-Co-Glycolic Acid) Nanosphere Uptake by Human Dendritic Cells and Macrophages In Vitro , 2002, Pharmaceutical Research.

[23]  Thommey P. Thomas,et al.  Design and Function of a Dendrimer-Based Therapeutic Nanodevice Targeted to Tumor Cells Through the Folate Receptor , 2002, Pharmaceutical Research.

[24]  P. Cullis,et al.  Drug Delivery Systems: Entering the Mainstream , 2004, Science.

[25]  V. Labhasetwar,et al.  Nanoparticle-mediated wild-type p53 gene delivery results in sustained antiproliferative activity in breast cancer cells. , 2004, Molecular pharmaceutics.

[26]  S. Nie,et al.  In vivo cancer targeting and imaging with semiconductor quantum dots , 2004, Nature Biotechnology.

[27]  T C Yih,et al.  Engineered nanoparticles as precise drug delivery systems , 2006, Journal of cellular biochemistry.

[28]  M. Gottikh,et al.  Optimisation of dendrimer‐mediated gene transfer by anionic oligomers , 2003, The journal of gene medicine.

[29]  J M Wilkinson,et al.  Nanotechnology applications in medicine. , 2003, Medical device technology.

[30]  S. Davis,et al.  Biomedical applications of nanotechnology--implications for drug targeting and gene therapy. , 1997, Trends in biotechnology.

[31]  S. Nie,et al.  Luminescent quantum dots for multiplexed biological detection and imaging. , 2002, Current opinion in biotechnology.

[32]  K. Arvidson,et al.  Rehabilitation of mandibular edentulism by single crystal sapphire implants and overdentures: 3-12 year results in 86 patients. A dual center international study. , 1996, Clinical oral implants research.

[33]  David Williams.  The risks of nanotechnology. , 2005, Medical device technology.

[34]  T. Ariga.  Gene therapy for primary immunodeficiency diseases: recent progress and misgivings. , 2006, Current pharmaceutical design.

[35]  M. Hamon,et al.  Pharmacological Approaches to the Prevention of Restenosis After Coronary Angioplasty , 1998, Drugs & aging.

[36]  K. Sayama,et al.  Cre‐loxP adenovirus‐mediated foreign gene expression in skin‐equivalent keratinocytes , 2005, The British journal of dermatology.

[37]  Jayanth Panyam,et al.  Biodegradable nanoparticles for drug and gene delivery to cells and tissue. , 2003, Advanced drug delivery reviews.

[38]  G Dan Hutcheson,et al.  The first nanochips. , 2004, Scientific American.

[39]  T. Tagawa,et al.  p53 gene therapy of human osteosarcoma using a transferrin-modified cationic liposome , 2005, Molecular Cancer Therapeutics.

[40]  Sanjiv S Gambhir,et al.  Self-illuminating quantum dot conjugates for in vivo imaging , 2006, Nature Biotechnology.

[41]  A. Rees,et al.  Vector-mediated drug delivery to the brain , 2001, Expert opinion on biological therapy.

[42]  M. Bednarski,et al.  Vascular-targeted nanoparticles for molecular imaging and therapy. , 2004, Methods in enzymology.

[43]  T. Yotsuyanagi,et al.  [Cationic liposomes in gene delivery]. , 1998, Nihon rinsho. Japanese journal of clinical medicine.

[44]  M. Addy,et al.  Etiology, mechanisms, and management of dentine hypersensitivity. , 1994, Current opinion in periodontology.

[45]  W. Young,et al.  A morphometric analysis of the cross-sectional area of dentine occupied by dentinal tubules in human third molar teeth. , 1994, International endodontic journal.

[46]  K. Jain.  The role of nanobiotechnology in drug discovery. , 2009, Advances in experimental medicine and biology.

[47]  P. Couvreur,et al.  Long-Circulating PEGylated Polycyanoacrylate Nanoparticles as New Drug Carrier for Brain Delivery , 2001, Pharmaceutical Research.

[48]  A. C. Hunter,et al.  Nanomedicine: current status and future prospects , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[49]  S. Simões,et al.  Cationic liposomes for gene delivery: novel cationic lipids and enhancement by proteins and peptides. , 2003, Current medicinal chemistry.

[50]  M. Zern,et al.  Poly(cationic lipid)-mediated in vivo gene delivery to mouse liver , 2003, Gene Therapy.

[51]  Gorka Orive,et al.  Drug delivery in biotechnology: present and future. , 2003, Current opinion in biotechnology.

[52]  Mohamed H. El-Shabouri,et al.  Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A. , 2002, International journal of pharmaceutics.

[53]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[54]  H. Slavkin.  Entering the era of molecular dentistry. , 1999, Journal of the American Dental Association.

[55]  E. Hersh,et al.  Cationic lipid-mediated gene transfer: current concepts. , 1999, Current opinion in molecular therapeutics.

[56]  L. Oesterle,et al.  Uprighting molars without extrusion. , 1999, Journal of the American Dental Association.

[57]  J L West,et al.  Applications of nanotechnology to biotechnology commentary. , 2000, Current opinion in biotechnology.

[58]  H. Maeda,et al.  Macromolecular therapeutics: advantages and prospects with special emphasis on solid tumour targeting. , 2003, Clinical pharmacokinetics.

[59]  T. Webster,et al.  Selective bone cell adhesion on formulations containing carbon nanofibers. , 2003, Biomaterials.

[60]  Igor L. Medintz,et al.  Quantum dot bioconjugates for imaging, labelling and sensing , 2005, Nature materials.

[61]  Z. Hao,et al.  p53 mediated sensitization of squamous cell carcinoma of the head and neck to radiotherapy , 1997, Oncogene.

[62]  Catherine Shaffer.  Nanomedicine transforms drug delivery. , 2005, Drug discovery today.

[63]  M. Weitzman,et al.  Gene therapy: twenty-first century medicine. , 2005, Annual review of biochemistry.

[64]  Warren C W Chan,et al.  Bionanotechnology progress and advances. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[65]  C Farr.  Biotech in periodontics: molecular engineering yields new therapies. , 1997, Dentistry today.

[66]  David Ure,et al.  Nanotechnology in dentistry: reduction to practice. , 2003, Dental update.

[67]  Henry Lin,et al.  Medical applications of nanotechnology. , 2006, The National medical journal of India.

[68]  Russell J Mumper,et al.  Microparticles and nanoparticles as delivery systems for DNA vaccines. , 2003, Critical reviews in therapeutic drug carrier systems.

[69]  Buddy D. Ratner,et al.  Template-imprinted nanostructured surfaces for protein recognition , 1999, Nature.

[70]  Y. Tsutsumi,et al.  [Development of nanomedicine using intracellular DDS]. , 2006, Nihon rinsho. Japanese journal of clinical medicine.

[71]  Si-Shen Feng,et al.  Nanoparticles of biodegradable polymers for clinical administration of paclitaxel. , 2004, Current medicinal chemistry.

[72]  S. Nie,et al.  Quantum dot bioconjugates for ultrasensitive nonisotopic detection. , 1998, Science.

[73]  L. Mazzola,et al.  Commercializing nanotechnology , 2003, Nature Biotechnology.

[74]  T. Webster,et al.  Specific proteins mediate enhanced osteoblast adhesion on nanophase ceramics. , 2000, Journal of biomedical materials research.

[75]  P. Cheng,et al.  p53 and PTEN/MMAC1/TEP1 gene therapy of human prostate PC-3 carcinoma xenograft, using transferrin-facilitated lipofection gene delivery strategy. , 2002, Human gene therapy.

[76]  P. Goldschmidt-Clermont,et al.  Tiny solutions for giant cardiac problems. , 2005, Trends in cardiovascular medicine.

[77]  V. Labhasetwar,et al.  Critical Determinants in PLGA/PLA Nanoparticle-Mediated Gene Expression , 2004, Pharmaceutical Research.

[78]  C. Johnson,et al.  A bioluminescence resonance energy transfer (BRET) system: application to interacting circadian clock proteins. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[79]  M. Rymaszewski,et al.  Intravascular and endobronchial DNA delivery to murine lung tissue using a novel, nonviral vector. , 2000, Human gene therapy.

[80]  Praveen Elamanchili,et al.  Biodegradable Nanoparticle Mediated Antigen Delivery to Human Cord Blood Derived Dendritic Cells for Induction of Primary T Cell Responses , 2003, Journal of drug targeting.

[81]  E. Chang,et al.  Tumor-targeted p53-gene therapy enhances the efficacy of conventional chemo/radiotherapy. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[82]  M Sugisaka,et al.  Nanotechnology on duty in medical applications. , 2005, Current pharmaceutical biotechnology.

[83]  O. Kayser,et al.  The impact of nanobiotechnology on the development of new drug delivery systems. , 2005, Current pharmaceutical biotechnology.

[84]  Thomas J Webster,et al.  Nanobiotechnology: implications for the future of nanotechnology in orthopedic applications , 2004, Expert review of medical devices.

[85]  A. J. Nijdam,et al.  Nanotechnologies for biomolecular detection and medical diagnostics. , 2006, Current opinion in chemical biology.

[86]  David Williams.  Nanotechnology: a new look. , 2004, Medical device technology.

[87]  C. Barcia,et al.  Regulatable gene expression systems for gene therapy applications: progress and future challenges. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[88]  E. Chang,et al.  Transferrin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts. , 1999, Human gene therapy.

[89]  Jicun Ren,et al.  Luminescent quantum dots: a very attractive and promising tool in biomedicine. , 2006, Current medicinal chemistry.

[90]  M. Yokoyama,et al.  Drug targeting with nano-sized carrier systems , 2005, Journal of Artificial Organs.

[91]  Naomi J Halas,et al.  Engineered nanomaterials for biophotonics applications: improving sensing, imaging, and therapeutics. , 2003, Annual review of biomedical engineering.

[92]  Jayanth Panyam,et al.  Rapid endo‐lysosomal escape of poly(DL‐lactide‐coglycolide) nanoparticles: implications for drug and gene delivery , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[93]  Kai Ewert,et al.  Lipoplex structures and their distinct cellular pathways. , 2005, Advances in genetics.

[94]  H. Maeda,et al.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[95]  K. Jain,et al.  Nanotechnology in clinical laboratory diagnostics. , 2005, Clinica chimica acta; international journal of clinical chemistry.

[96]  Shuming Nie,et al.  Multicolor quantum dots for molecular diagnostics of cancer , 2006, Expert review of molecular diagnostics.

[97]  M. Alonso,et al.  Nanoparticles as carriers for nasal vaccine delivery , 2005, Expert review of vaccines.

[98]  K. Jain,et al.  Nanodiagnostics: application of nanotechnology in molecular diagnostics , 2003, Expert review of molecular diagnostics.

[99]  M. A. Arangoa,et al.  Nanoparticles with specific bioadhesive properties to circumvent the pre-systemic degradation of fluorinated pyrimidines. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[100]  G. Whitesides.  The 'right' size in nanobiotechnology , 2003, Nature Biotechnology.

[101]  D. Wells,et al.  Gene Therapy Progress and Prospects: Electroporation and other physical methods , 2004, Gene Therapy.

[102]  V. Labhasetwar,et al.  Targeted Drug Delivery in Cancer Therapy , 2005, Technology in cancer research & treatment.

[103]  P. Couvreur,et al.  Intraocular injection of tamoxifen‐loaded nanoparticles: a new treatment of experimental autoimmune uveoretinitis , 2004, European journal of immunology.

[104]  D. Balding,et al.  HLA Sequence Polymorphism and the Origin of Humans , 2006 .

[105]  P. Couvreur,et al.  Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles , 1992, Investigational New Drugs.

[106]  Ramya B. Nagaraja.  Converging Technologies for Improving Human Performance , 2004 .

[107]  V. Labhasetwar.  Nanotechnology for drug and gene therapy: the importance of understanding molecular mechanisms of delivery. , 2005, Current opinion in biotechnology.

[108]  H. Yeh,et al.  Single-quantum-dot-based DNA nanosensor , 2005, Nature materials.

[109]  Thomas J. Webster,et al.  Nano-biotechnology: carbon nanofibres as improved neural and orthopaedic implants , 2004, Nanotechnology.

[110]  M. Ferrari,et al.  Medical nanotechnology: shortening clinical trials and regulatory pathways? , 2005, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.

[111]  S. Hart.  Lipid carriers for gene therapy. , 2005, Current drug delivery.

[112]  A. Domb,et al.  Protein and peptide parenteral controlled delivery , 2004, Expert opinion on biological therapy.

[113]  Lin He,et al.  Particles for multiplexed analysis in solution: detection and identification of striped metallic particles using optical microscopy. , 2002, Analytical chemistry.

[114]  Erkki Ruoslahti,et al.  Nanocrystal targeting in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[115]  J Arends,et al.  The diameter of dentinal tubules in human coronal dentine after demineralization and air drying. A combined light microscopy and SEM study. , 1995, Caries research.

[116]  Jain Kk,et al.  Nanodiagnostics: application of nanotechnology in molecular diagnostics , 2003, Expert review of molecular diagnostics.

[117]  Patrick Winter,et al.  Applications of Nanotechnology to Atherosclerosis, Thrombosis, and Vascular Biology , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[118]  Gilles Ponchel,et al.  Gliadin Nanoparticles as Carriers for the Oral Administration of Lipophilic Drugs. Relationships Between Bioadhesion and Pharmacokinetics , 2001, Pharmaceutical Research.

[119]  Larry J Kricka,et al.  Microchips, Microarrays, Biochips and Nanochips - Personal Laboratories for the 21st Century , 2000, EJIFCC.

[120]  V. Labhasetwar,et al.  Nanosystems in Drug Targeting: Opportunities and Challenges , 2005 .

[121]  P. Alivisatos.  The use of nanocrystals in biological detection , 2004, Nature Biotechnology.

[122]  R. Freitas.  What is nanomedicine? , 2005, Nanomedicine : nanotechnology, biology, and medicine.

[123]  M. Roco.  Nanotechnology: convergence with modern biology and medicine. , 2003, Current opinion in biotechnology.

[124]  C. Mayer.  Nanocapsules as Drug Delivery Systems , 2005, The International journal of artificial organs.

[125]  Christopher G Thanos,et al.  Nanotechnology and medicine , 2003, Expert opinion on biological therapy.

[126]  L. Young,et al.  Viral gene therapy strategies: from basic science to clinical application , 2006, The Journal of pathology.

[127]  Peter X Ma,et al.  Nano-fibrous scaffolding architecture selectively enhances protein adsorption contributing to cell attachment. , 2003, Journal of biomedical materials research. Part A.

[128]  S. Gambhir,et al.  Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics , 2005, Science.

[129]  P. Couvreur,et al.  Nanoparticles in cancer therapy and diagnosis. , 2002, Advanced drug delivery reviews.